Engineering next-generation organoids: A review on bioprinting strategies, bioink innovations, and frontier applications
Journal of Tissue Engineering · 2026-06 · 17
DOI: 10.1177/20417314261459941 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Tissue Engineering, online erschienen am 12.06.2026. Verfasst von Defeng Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Nankai University, Tianjin, China. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tianjin Key Medical Discipline Construction Project, Tianjin Natural Science Foundation, Tianjin “131” talent training project.
Abstract (Originalsprache)
While organoids hold immense promise as in vitro three-dimensional (3D) models, their translational utility is fundamentally constrained by passive diffusion limits (>800 μm), which inevitably trigger necrotic core formation and stochastic structural heterogeneity. This review elucidates how bioprinting shatters these physical bottlenecks by executing a paradigm shift toward spatiotemporal determinism. We systematically decode the mechanobiological evolution of bioinks—charting the transition from exogenous static matrices, which now function as temporal controllers via tunable stress relaxation to direct YAP/TAZ mechanotransduction, to the emerging paradigm of “engineerable living bioinks” driven by endogenous, cadherin-mediated fluid-to-solid jamming transitions. Furthermore, we critically evaluate frontier spatial strategies, highlighting how sacrificial networks and deterministic multi-material assembly establish active convective infrastructures and precise biophysical boundary conditions. By enforcing this rigorous baseline, these technologies definitively rectify pharmacokinetic/pharmacodynamic (PK/PD) distortions—eradicating false-positive noise in high-throughput screening and bridging the post-implantation mass transport vacuum—elevating organoids from stochastic clusters to highly predictive pathophysiological macro-models. Ultimately, we posit that transitioning from isolated morphological fabrication to resolving the inherent systemic metabolic paradoxes of multi-lineage integration is the absolute prerequisite for clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Nankai University, Tianjin, China.
- School of Pharmacy, Tianjin Medical University, Tianjin, China.
- School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
- MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Laboratory of Flexible Electronics Technology, Center for Synthetic and Systems Biology, Tsinghua-Peking Center for Life Science, Department of…
- College of Pharmacy, Nankai University, Tianjin, China.
- OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
ORCID-Profile: Defeng Sun
Förderung
- Tianjin Key Medical Discipline Construction Project
- Tianjin Natural Science Foundation
- Tianjin “131” talent training project
Zitieren
APA
Sun, D., Fan, X., Sun, H., Li, D., Shen, R., Xia, P., & Zhao, Z. (2026). Engineering next-generation organoids: A review on bioprinting strategies, bioink innovations, and frontier applications. Journal of Tissue Engineering, 17. https://doi.org/10.1177/20417314261459941
Vancouver
Sun D, Fan X, Sun H, Li D, Shen R, Xia P, et al. Engineering next-generation organoids: A review on bioprinting strategies, bioink innovations, and frontier applications. Journal of Tissue Engineering. 2026;17. doi:10.1177/20417314261459941
BibTeX
@article{Sun2026,
author = {Sun, Defeng and Fan, Xuemei and Sun, Hua and Li, Dongmei and Shen, Ruijia and Xia, Pu and Zhao, Zhenying},
title = {Engineering next-generation organoids: A review on bioprinting strategies, bioink innovations, and frontier applications},
journal = {Journal of Tissue Engineering},
year = {2026},
volume = {17},
doi = {10.1177/20417314261459941}
}
EUVIMED